EDIT
Editas Medicine Inc
NASDAQ: EDIT · HEALTHCARE · BIOTECHNOLOGY
$2.82
-7.84% today
Updated 2026-04-29
Market cap
$284.81M
P/E ratio
—
P/S ratio
7.03x
EPS (TTM)
$-1.80
Dividend yield
—
52W range
$1 – $5
Volume
1.7M
Editas Medicine Inc (EDIT) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
3 of 8
Last 8 quarters
Avg EPS surprise
-4.1%
Last 4 quarters
Revenue YoY growth
-19.2%
Most recent quarter
EPS YoY growth
+89.1%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+5.9%
Last 2 reports
Positive reaction rate
100%
2 of 2 quarters
Largest single-day move
+7.7%
2025-11-10
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-02-19 | $-0.06 | +73.9% | $1.72 | $1.79 | +4.1% |
| 2025-11-10 | $-0.28 | +6.7% | $2.47 | $2.66 | +7.7% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.23 | $-0.06 | +73.9% | $24.74M | -19.2% |
| 2025-09-30 | $-0.30 | $-0.28 | +6.7% | $7.54M | +12265.6% |
| 2025-06-30 | $-0.40 | $-0.63 | -57.5% | $3.58M | +597.5% |
| 2025-03-31 | $-0.66 | $-0.92 | -39.4% | $4.66M | +310.4% |
| 2024-12-31 | $-0.33 | $-0.55 | -67.4% | $30.60M | -49.0% |
| 2024-09-30 | $-0.75 | $-0.75 | +0.0% | $61000.00 | -98.9% |
| 2024-06-30 | $-0.70 | $-0.82 | -17.1% | $513000.00 | -82.2% |
| 2024-03-31 | $-0.66 | $-0.76 | -15.2% | $1.14M | -88.5% |
| 2023-12-31 | $-0.54 | $-0.23 | +57.4% | $60.05M | — |
| 2023-09-30 | $-0.57 | $-0.55 | +3.5% | $5.34M | — |
| 2023-06-30 | $-0.76 | $-0.56 | +26.3% | $2.89M | — |
| 2023-03-31 | $-0.78 | $-0.71 | +9.0% | $9.85M | — |
| 2022-12-31 | $-0.80 | $-0.88 | -10.0% | — | — |
Frequently asked questions
Has Editas Medicine Inc beaten earnings estimates?
Editas Medicine Inc has beaten Wall Street EPS estimates in 3 of its last 8 quarterly reports, with an average EPS surprise of -4.1% over the last 4 quarters.
How does EDIT stock react to earnings?
EDIT stock has moved an average of +5.9% in the trading day following earnings over its last 2 reports, with positive reactions in 100% of those quarters.
What is Editas Medicine Inc's revenue growth rate?
Editas Medicine Inc reported year-over-year revenue growth of -19.2% in its most recent quarter, with EPS growing +89.1% year-over-year.